Company intelligence / Profile preview

Myka Labs

San Francisco, California, United Statesmyka.bio ↗

Ownership: Private
Development stage: Preclinical

Overview

Myka Labs has developed a pipeline of interventional systems leveraging real-time multimodal artificial intelligence for imaging and guidance during surgery. Their technologies are being clinically evaluated for improving outcomes in complex abdominal interventions, including cancer surgeries and congenital repairs. Recent clinical experience with their Connect-EA system was presented at a pediatric surgery conference in January 2025, highlighting ongoing clinical progress.[1][4]

Therapeutic areas: OncologyRare DiseasesGastroenterology
Modalities: DeviceArtificial intelligence-based systemImaging/guidance technology
Industry: Surgical Medical Devices

Partnerships

Mayo Clinic (landmark partnership to develop next-generation AI for surgery)

Beyond the preview

Go deeper on Myka Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myka Labs.

Explore the full profile